Avalon, GSK Extend Their Collaboration with Startup Focused on ALS – Xconomy

Avalon, GSK Extend Their Collaboration with Startup Focused on ALS
Xconomy
San Diego’s Avalon Ventures has started a new biotech focused on Lou Gehrig’s disease, the neuro-degenerative disease that claimed the life of the Hall of Fame New York Yankees first baseman, whose endurance gave rise to his nickname as “the Iron …

and more

…read more

From:: Startup Tech News From Google News

Leave a Comment